Sign inJoin waitlistJoin the waitlist

Richard Deming

Endowed Chair in Medical Humanities · Creighton University School of Medicine

Credentials: · · ·

History

Creighton University School of Medicine
Present

Radiation Oncology
University of California-San Francisco
1985–1989
Radiology-Diagnostic
Walter Reed National Military Medical Center
1981–1985
Preliminary Internal Medicine
Naval Medical Center
1980–1981
Creighton University School of Medicine
1976–1980
South Dakota State University
1972–1976

Research

Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases: A Randomized Clinical Trial
JAMA · 2016 · 1,394 citations
Mometasone furoate effect on acute skin toxicity in breast cancer patients receiving radiotherapy: a phase III double-blind, randomized trial from the North Central Cancer…
International journal of radiation oncology · 2011 · 110 citations
Prognostic factors differ by tumor stage for small cell lung cancer: a pooled analysis of North Central Cancer Treatment Group trials
Cancer · 2009 · 105 citations

JM
James Martenson
5 papers
SS
Steven Schild
5 papers
AC
Allen Chauvenet
4 papers
AE
Arthur Elman
4 papers
Daniel Dosoretz
4 papers
DP
David Pistenmaa
4 papers
HW
Harvey Wolkov
4 papers
Joachim Yahalom
4 papers
John Glick
4 papers
LP
Leonard Prosnitz
4 papers
Louis Constine
4 papers
PM
Peter Mauch
4 papers

Clinical trials

Serum-derived Bovine Immunoglobulin Effect on Mucositis
Principal investigator · Terminated · Phase 2
MercyOne Des Moines Medical Center
2020–2023
Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial
Site PI · Recruiting · Phase 3
National Cancer Institute (NCI)
2026–2029
Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
Site PI · Recruiting · Phase 3
Alliance for Clinical Trials in Oncology
2026–2040
Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
Site PI · Recruiting · Phase 3
SWOG Cancer Research Network
2026–2030